Authorized Generics, ANDA products, and services
Founded in 1993, Greenstone LLC is a wholly owned subsidiary of Pfizer Inc—the world’s largest research-based pharmaceutical company.1 The mission we share at Greenstone is to leverage our expertise to provide reliable, quality generic medications and exceptional value to our customers.
The generic specialists
At Greenstone, you’ll find an accomplished team of sales and business professionals who bring proven experience in health sciences, financing, marketing, and operations to every product and project.
From executing short-term loss of exclusivity strategies to negotiating the authorized generic marketplace we helped pioneer,2-4 Greenstone can provide critical support in a wide range of areas, including:
- Financial modeling
- Pricing analytics
- Commercial launch and supply-chain management
- Rebate administration
- Operational services
Greenstone LLC at a Glance
- Top 10 generics company5
- Launched more than 80 products and 450 SKUs6
- 5 national account directors providing extensive industry experience
- 2-time Diana Award recipient7*
Our portfolio of products includes:
Authorized Generic (AG) Products. As a leader in authorized generics marketing, we partner with innovator brand teams to help make post-exclusivity products widely available to distributors, pharmacy networks, and independent owners.
Abbreviated New Drug Application (ANDA) Products. Through strategic acquisitions and alliances, Greenstone has established a robust portfolio of ANDA tablets and capsules across a broad range of therapeutic areas.
Behind all of our products and specialties is a commitment to delivering quality medicines to patients, and delivering exceptional services to our partners and customers.
*Healthcare Distribution Management Association (HDMA) award for excellence.
References: 1. Pfizer: the world’s largest research-based pharmaceutical company. Pfizer Web site. http://www.pfizer.com/home/. Accessed May 8, 2012. 2. Data on file. Onboard meeting. Greenstone LLC, Peapack, NJ; 2011. 3. Reiffen D, Ward MR. “Branded generics” as a strategy to limit cannibalization of pharmaceutical markets. Federal Trade Commission Web site. http://www.ftc.gov/be/healthcare/wp/12_Reiffen_BrandedGenericsAsAStrategy.pdf. Published May 2005. Accessed May 8, 2012. 4. Clindamycin hydrochloride capsules, USP [package insert]. Peapack, NJ: Greenstone LLC; 2008. 5. IMS DATA, 2012. 6. Product catalog 2012. Greenstone Web site. http://www.greenstonellc.com/catalog/Greenstone_Product_Catalog.pdf. Accessed May 8, 2012. 7. The Diana Award past winners. Healthcare Distribution Management Association Web site. http://www.healthcaredistribution.org/membership/award_diana_pastwinners.asp. Accessed May 8, 2012.